Request Demo
Last update 30 Mar 2025
Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)
Last update 30 Mar 2025
Overview
Basic Info
Drug Type Interferons |
Synonyms Interferon alpha-2b (Hanmi Pharma), LAPS-IFNa, HM 10660A + [2] |
Target |
Action agonists |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
10
Clinical Trials associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)PACTR202302902720138
COMPARATIVE STUDY ON THE EFFICACY OF INTRALESIONAL MITOMYCIN C TO INTERFERON ALPHA-2B IN THE MANAGEMENT OF PRIMARY PTERYGIUM AT THE EYE CLINIC OF LAGOS STATE UNIVERSITY TEACHING HOSPITAL, IKEJA
IRCT20220215054028N1
A comparative study of recurrence rate and complications between mitomycin c, interferone alpha 2b and bevasizumab after primary pterygium surgery
NCT02057887
Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
100 Clinical Results associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)
Login to view more data
5
Literatures (Medical) associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)01 Apr 2020CorneaQ3 · MEDICINE
Q3 · MEDICINE
Letter
Author: Luo, Fei ; Zhang, Yingnan ; Li, Hang ; Dai, Honglei ; Pan, Zhiqiang ; Yin, Mingyang
01 Dec 2017International journal of pharmaceuticsQ2 · MEDICINE
Q2 · MEDICINE
Article
Author: Choi, Inyoung ; Lim, Chaemin ; Sim, Taehoon ; Lee, Jongsoo ; Jung, Sungyoub ; Bae, Sungmin ; Park, Youngjin ; Kwon, Sechang ; Oh, Kyung Taek ; Kim, Daejin
01 Sep 2002Der InternistQ4 · MEDICINE
Akute Hepatitis C Therapie mit Interferon α-2b
Q4 · MEDICINE
Article
Author: H. E. Blum ; R. Thimme
100 Deals associated with Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.) | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic hepatitis C genotype 1 | Phase 2 | Mexico | 01 Jul 2013 | |
| Hepatitis C, Chronic | Phase 2 | Mexico | 01 Jul 2013 | |
| Hepatitis C | Phase 2 | Netherlands | - | |
| Neoplasms | Phase 2 | Netherlands | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 140 | Full-dose BCG | fxzowszlwa(vkbxrnssfy) = kvarxmiykv bxslhdnxfd (kkrdnfmfph ) View more | - | 01 Apr 2014 | ||
Low-dose BCG plus IFNα-2b | fxzowszlwa(vkbxrnssfy) = yrejhrobpb bxslhdnxfd (kkrdnfmfph ) View more | ||||||
Phase 3 | Melanoma Adjuvant | 432 | vvfnphnxai(zicmirwjui) = vutdndrvez xuihoivivu (vyloydhskc, 4.5–9.3) View more | Positive | 20 May 2012 | ||
Cisplatin, vinblastine, DTIC plus IL-2 and interferon | vvfnphnxai(zicmirwjui) = fkhymhjasj xuihoivivu (vyloydhskc ) View more | ||||||
Phase 2 | 25 | lflmpnmsnq(xjffzxyvtb) = orhcybhbxg egxelrowss (mviztoppeq ) View more | Positive | 20 May 2010 | |||
Phase 2 | 36 | hamysxzmrj(fkamuzwfcw) = iqgiyiobpg liamhyiqyw (wqiterjgyb, 0.370 - 0.739) View more | Positive | 20 May 2010 | |||
Not Applicable | Melanoma Adjuvant | - | wcixeibtuh(lzlhtyegvf) = wnvpczgcmp qjkjclrztv (yomwbazvwc, 34.9–90.7) View more | - | 01 Jun 2005 | ||
Phase 3 | 180 | msfjuqxwlh(fknpmuonra) = sclfcvmeyu bfvhybbneq (wuhqinwrmq ) View more | - | 15 Jul 2004 | |||
msfjuqxwlh(fknpmuonra) = kxbuthtrzo bfvhybbneq (wuhqinwrmq ) View more | |||||||
Phase 2 | 26 | eqjskciezu(wyhestfeaj) = pwdnlitetf vqsouocuwi (donfgkaxqd, 40 - 79) View more | Negative | 15 Jul 2004 | |||
Not Applicable | 226 | pmrlptjfft(onkvytyvxy) = xlmnssukkp rfgbgrpwid (pazankomcr ) View more | - | 01 Jan 2002 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free